FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to biotechnology. What is presented is a method of treating a mammal suffering an inflammatory disease wherein the inflammatory disease is atopic dermatitis, eczema, or itch. The method comprises administering to a mammal a recovered monoclonal antibody or antigen-binding fragment thereof which is prepared by inoculating a non-human animal an adjuvant and a polypeptide (zcytor17lig) containing amino acid residues 27-164 SEQ ID NO: 2, followed by recovering said antibodies from said animal.
EFFECT: using the invention can find application in medicine for treating atopic dermatitis, eczema, or itch.
2 cl, 7 dwg, 21 tbl
Title | Year | Author | Number |
---|---|---|---|
NEW CYTOKINE ZALPHA 11-LIGAND | 2000 |
|
RU2258710C2 |
INTERFERON-LIKE PROTEIN ZCYTO21 | 2001 |
|
RU2292394C2 |
HOMOGENOUS PREPARATIONS OF IL-28 AND IL-29 | 2004 |
|
RU2518324C2 |
POLYPEPTIDE WITH ANTIVIRAL ACTIVITY, ITS PRODUCTION AND USE | 2004 |
|
RU2372356C2 |
ISOLATED SOLUBLE IL-20 RECEPTOR (VARIANTS) | 2000 |
|
RU2279441C2 |
IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USING | 2006 |
|
RU2444528C2 |
METHOD AND SET FOR DETECTING GENE ENCODING MEMBRANE-BOUND PROTEIN, VECTOR (VARIANTS) | 1999 |
|
RU2246538C2 |
HETERODIMERIC POLIPEPTIDES IL-17 A/F AND POSSIBILITIES OF THEIR THERAPEUTIC APPLICATION | 2007 |
|
RU2440134C2 |
THROMBOPOIETIN | 1994 |
|
RU2245365C2 |
HEMOPOIETIC PROTEIN (VARIANTS), DNA SEQUENCE, METHOD FOR PREPARING HEMOPOIETIC PROTEIN, METHOD FOR SELECTIVE EXPANSION OF HEMOPOIETIC CELLS, METHOD FOR PRODUCING DENDRITIC CELLS, METHOD FOR STIMULATING FOR PRODUCING HEMOPOIETIC CELLS IN PATIENT, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT | 1997 |
|
RU2245887C2 |
Authors
Dates
2013-08-20—Published
2003-01-21—Filed